This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

LabMD, CEO ask US appeals court to revive claims against FTC staffers

( January 19, 2023, 22:31 GMT | Official Statement) -- MLex Summary: LabMD and its chief operating officer asked the US Court of Appeals for the DC Circuit to revive its case against three US Federal Trade Commission attorneys. They said that their proposed amended complaint are contains allegations informed by diligent investigation and new factual revelations that could not have been discovered before the original complaint was filed. “In many instances, the FTC and defendants actively concealed relevant facts from the courts and LabMD and Daugherty. The district court summarily denied LabMD’s motion for leave to amend the complaint without giving the motion any consideration.”See document below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login